| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977599A1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations |
| 02/09/2000 | EP0977594A1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 02/09/2000 | EP0977582A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 02/09/2000 | EP0977561A1 Glucosamine fatty acid compositions and their use |
| 02/09/2000 | EP0977546A1 Use of unsaturated aldehydes in dying fibers containing keratin |
| 02/09/2000 | CN1244118A Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant |
| 02/09/2000 | CN1244115A Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres |
| 02/09/2000 | CN1244114A Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres |
| 02/08/2000 | US6022896 Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids |
| 02/08/2000 | US6022528 Effervescent oral care with improved interproximal delivery properties and taste, comprising an alkali metal bicarbonate and second composition with specific amount of acidic compound to generate carbon dioxide without acidic salica |
| 02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/03/2000 | WO2000004890A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | WO1999064417A3 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/03/2000 | WO1999058145A3 Immunomodulators for vaccines |
| 02/03/2000 | CA2338345A1 Encapsulation of water soluble peptides |
| 02/03/2000 | CA2338211A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
| 02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/02/2000 | EP0976393A1 Composition containing an opacifying or pearlescent agent and at least one fatty alcohol |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 02/02/2000 | EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
| 02/02/2000 | EP0975318A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres |
| 02/02/2000 | CN1243436A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 02/02/2000 | CN1243433A Personal cleansing compositions |
| 02/02/2000 | CN1243432A Personal cleansing compositions |
| 02/02/2000 | CN1243430A Oxidising composition and uses for dyeing, permanently setting or bleaching kerutin fibres |
| 02/01/2000 | US6019992 Cosmetic skin care compositions containing 4-chromanone |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 01/27/2000 | WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | WO2000003992A1 Quinoline derivatives |
| 01/27/2000 | WO2000003742A2 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 01/27/2000 | WO2000003705A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 01/27/2000 | WO2000003686A2 Acne treatment compositions |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/26/2000 | EP0974356A1 Tablets comprising a combination of metformin and glibenclamide |
| 01/26/2000 | EP0974336A2 Composition for oxidative dying of keratinous fibres and dying process therewith |
| 01/26/2000 | EP0973729A1 A process for the preparation of 4-bromomethyl diphenyl compounds |
| 01/26/2000 | EP0973534A1 Pharmaceutical compositions having appetite suppressant activity |
| 01/26/2000 | EP0973505A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/26/2000 | EP0973492A1 Antiperspirant stick with improved characteristics |
| 01/26/2000 | EP0973483A1 Foaming personal cleansing product |
| 01/26/2000 | EP0722316B1 New emulsion formulation |
| 01/26/2000 | CN1242701A Compositions contg. antifungal and cationic agent |
| 01/26/2000 | CN1242697A Oxidation dyeing composition for keratin fibers and dyeing method using said composition |
| 01/26/2000 | CN1242367A Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole] |
| 01/26/2000 | CN1048722C (S) (+)-2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid pharmaceutical compositions contg. same, and process for prepn. |
| 01/25/2000 | CA2073055C Nicotine containing stimulant unit |
| 01/25/2000 | CA2002850C Technetium-99m complex for examining the renal function |
| 01/20/2000 | WO2000003014A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | WO2000002570A1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 01/20/2000 | WO2000002521A2 Symptomatic relief of allergic reactions |
| 01/20/2000 | CA2336805A1 Pharmaceutical uses of nab1 and nab2 |
| 01/19/2000 | EP0972010A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
| 01/19/2000 | EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971722A1 An aphrodisiac for application to the sexual organs |
| 01/19/2000 | CN1241936A Antiperspirant composition |
| 01/19/2000 | CN1048492C Quinuclidine derivatives and its preparation |
| 01/18/2000 | US6015574 Multilayer phosphatides, amphoteric surfactants, nonionic surfactants for lipophilic material |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001667A1 SUBSTITUTED β-DIKETONES AND THEIR USE |
| 01/13/2000 | WO2000001415A2 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/13/2000 | CA2336709A1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/13/2000 | CA2336300A1 Substituted .beta.-diketones and their use |
| 01/12/2000 | EP0970687A1 Composition for dyeing keratinous fibres containing a cationic direct dye and a thickening polymer |
| 01/12/2000 | EP0970686A1 Composition for dyeing keratinous fibres containing a cationic direct dye and a thickening polymer |
| 01/12/2000 | EP0970685A1 Composition for dyeing keratinous fibres containing a cationic direct dye and a thickening polymer |
| 01/12/2000 | EP0970684A1 Composition for dyeing keratinous fibres containing a cationic direct dye and a thickening polymer |
| 01/12/2000 | EP0969878A1 Method for detecting abnormal epithelial cell shedding |
| 01/12/2000 | EP0969836A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/12/2000 | EP0969819A2 New crystalline form of omeprazole |
| 01/12/2000 | EP0969818A1 Dosage forms comprising separate portions of r- and s-enantiomers |
| 01/12/2000 | EP0969815A2 Pharmaceutical compositions |
| 01/12/2000 | EP0969799A1 Oxidation dyeing composition for keratin fibres and dyeing method using said composition |
| 01/12/2000 | EP0969797A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres |
| 01/12/2000 | EP0969795A1 Oxidising composition and uses for dyeing, permanently setting or bleaching keratin fibres |
| 01/12/2000 | EP0656781B1 Composition comprising fertilized shell eggs |
| 01/12/2000 | CN1241181A Pharmaceutical compounds |
| 01/12/2000 | CN1241138A Oxidation dyeing composition for keratin fibres and dyeing method using said composition |
| 01/11/2000 | US6013796 Simplification, efficiency, nontoxic |
| 01/11/2000 | US6013264 Comprising hepatitis b surface antigen (hbsag); stability, efficiency; for immunization against diphtheria, tetanus, pertussis, polio, haemophilus influenzae b, hepatitis a, meningitis a, meningitis b, meningitis c, and otitis media |
| 01/09/2000 | CA2277355A1 Keratin fibre dye composition with a cationic direct colorant and a thickening polymer |
| 01/09/2000 | CA2277353A1 Keratin fibre dye composition with a cationic direct colorant and a thickening polymer |
| 01/09/2000 | CA2277347A1 Keratin fibre dye composition with a cationic direct colorant and a thickening polymer |
| 01/09/2000 | CA2277345A1 Keratin fibre dye composition with a cationic direct coloring and a thickening polymer |
| 01/06/2000 | WO2000000211A2 Hydrocolloids obtained from portulaca oleracea and the use thereof |
| 01/06/2000 | WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/06/2000 | CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/05/2000 | EP0968158A1 Preparation of preparing substituted indanones |
| 01/05/2000 | EP0967991A1 Infectious bursitis vaccine |
| 01/05/2000 | EP0967957A1 Personal cleansing compositions |
| 01/05/2000 | EP0760646B1 Combined two-part reducing agent/humectant shaving system for improved shaving comfort |
| 01/05/2000 | CN1240132A Controlled release formulation |
| 01/05/2000 | CN1048017C Novel phosphonocarboxylate compounds and pharmaceutical compositions containing same |